MedTrace Logo

Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome.

NCT05016024 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2023-02-16

No results posted yet for this study

Summary

This study is aimed to investigate the efficacy and safety of Colilen IBS, a Medical Device made of natural substances, even when taken in addition to other therapies, for the treatment of Irritable Bowel Syndrome.

Conditions

  • Irritable Bowel Syndrome

Interventions

DEVICE

Colilen IBS

Patients will take Colilen IBS in First or Second Period

OTHER

Placebo

Patients will take PlaceboS in First or Second Period

Sponsors & Collaborators

  • IQVIA RDS Inc.

    collaborator INDUSTRY

  • IQVIA Solutions

    collaborator UNKNOWN

  • Aboca Spa Societa' Agricola

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-05
Primary Completion
2023-02-15
Completion
2023-02-15

Countries

  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05016024 on ClinicalTrials.gov